Felix Registration Achieved in Turkey, Sales Commence
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Memphasys Ltd has announced the successful registration of its Felix™ System in Turkey, allowing for the commencement of commercial sales under the ITL agreement. The initial sale includes a significant number of cartridges and consoles, marking the start of operations in a large assisted-reproduction market. The company has completed training for local distributors to facilitate product demonstrations and further sales growth in Turkey. Memphasys expects additional orders as IVF clinics engage with their commercial partners in the region.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Memphasys
- Notification of cessation of securities - MEM
- EUR526,500 Nordic Agreement Expands Felix European Footprint
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and 2026 Annual Report
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
Later from Memphasys
- Investor Webinar Invite
- Memphasys Investor Webinar Presentation - September 2026
- Memphasys Secures European Felix Agreement
- Application for quotation of securities - MEM
- Notification regarding unquoted securities - MEM
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys